About 400 reports

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Regenerative Medicine Market Report The regenerative medicine market size to grow at a CAGR of around 34% during the period 2020-2026. Increased R&D investments by pharmaceutical companies will drive the demand for regenerative medicines....

  • Regenerative Medicine
  • World
  • Health Expenditure
  • Cancer Incidence

Major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc., Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies and CellGenix. The global regenerative medicine for cartilage market is...

  • Regenerative Medicine
  • World
  • APAC
  • United Kingdom
  • Biologics Sales

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology,...

  • Regenerative Medicine
  • World
  • APAC
  • Chronic Disease Prevalence

The global regenerative medicine market is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9% during the forecast period. Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline...

  • Regenerative Medicine
  • United States
  • Europe
  • APAC
  • North America
  • Chronic Disease Prevalence
  • Health Expenditure

Regenerative Medicines market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Regenerative Medicines Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Regenerative Medicines types, applications. Further, Regenerative...

  • Regenerative Medicine
  • World

Regenerative Therapies Market: Report Scope This reportexamines the regenerative therapies market for the period 2021 - 2031. The primary objective of the report is to offer insights into developments in the regenerative therapies market that are significantly helping transform the growth trajectory of global businesses...

  • Regenerative Medicine
  • World

The Global Regenerative Medicine Partnering Terms and Agreements 2015-2022 report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

  • Regenerative Medicine
  • World

Major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix, Osiris Therapeutics Inc., and DePuy Synthes. The global regenerative...

  • Regenerative Medicine
  • World
  • United States
  • APAC
  • United Kingdom
  • Biologics Sales

Global Regenerative Medicines Market to Reach $87.03 Billion by 2030 Market Report Coverage - Regenerative Medicines Market Segmentation • Product – Tissue Engineering (Allogeneic Tissue, Autologous Tissue, Xenogeneic Tissue, and Synthetic Tissue), Stem Cells (Stem Cell Services...

  • Regenerative Medicine
  • World
  • APAC
  • Drug Approval

Regenerative Medicine Market Research Report: By Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Application (Musculoskeletal, Wound Care, Oncology, Dental, Ocular) - Global Industry Analysis and Demand Forecast to 2030 Over 17.9 million people die of cardiovascular diseases (CVDs) and 9.6 million of...

  • Regenerative Medicine
  • World
  • APAC
  • Mortality Rate

Regenerative Medicines Market Report Overview Regenerative Medicines market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Regenerative Medicines market types and applications. It is a focused study on Regenerative Medicines market space...

  • Regenerative Medicine
  • World
  • APAC
  • Health Provider Density

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Cell Therapy
  • World
  • China

Abstract: - Global Allogeneic Stem Cells Market to Reach $1.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Allogeneic Stem Cells estimated at US$666.3 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 10.6% over the period 2020-2027....

  • Drug Development
  • Regenerative Medicine
  • World
  • China
  • United States

Regenerative Medicine Market – Scope of Report This report on the global regenerative medicine market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2021 to 2028.The report provides revenue of the global regenerative...

  • Regenerative Medicine
  • World

The government funding for the development of regenerative medicine has been increasing in most developed countries, because of its applications in organ transplantation, tissue engineering, and various other applications. In the United States, two major government agencies, National Institutes of Health (NIH) and California Institute of Regenerative...

  • Cell Therapy
  • Regenerative Medicine
  • Therapy
  • APAC
  • Europe
  • Cancer Incidence
  • Cancer Mortality

Abstract: - Global Regenerative Medicine Market to Reach $50.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Regenerative Medicine estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$50.2 Billion by 2027, growing at a CAGR of 22.3% over the analysis period...

  • Regenerative Medicine
  • World
  • China
  • United States

This report is 90% complete and will include the latest impact analysis of Covid-19 along with updated quarterly market data for the year 2021 estimated. This report will be delivered within three working days post order confirmation. United States Regenerative Medicine Market By Type (Cell Therapies, Gene Therapies,...

  • Regenerative Medicine
  • Cell Therapy
  • United States

Global Regenerative Medicines Market 2022-2026 The analyst has been monitoring the regenerative medicines market and it is poised to grow by $ 28.67 bn during 2022-2026, accelerating at a CAGR of 14.57% during the forecast period. Our report on the regenerative medicines market provides a holistic analysis, market size...

  • Regenerative Medicine
  • World
  • Chronic Disease Prevalence

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Cell Therapy
  • World
  • China
  • APAC

Abstract: - Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR...

  • Cell Therapy
  • Tissue Engineering
  • World
  • China
  • United States

The Europe cell line development serum market is expected to reach US$ 422.61 million in 2027 from US$ 268.68 million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020 to 2027. Increasing adoption of regenerative medicines, rising prevalence of cancer across the world, and increasing investments in R&D by pharmaceutical...

  • Cell Therapy
  • Europe
  • Foreign Direct Investment
  • Final Consumption Expenditures

The Middle East and Africa cell line development serum market is expected to reach US$ 76.04 million in 2027 from US$ 55.54 million in 2019. The market is estimated to grow at a CAGR of 4.0% from 2020 to 2027. Increasing adoption of regenerative medicines, rising prevalence of cancer across the world, and increasing investments in R&D by...

  • Cell Therapy
  • Middle East
  • Africa
  • Health Expenditure
  • Foreign Direct Investment

The South and Central America cell line development serum market is expected to reach US$ 103.49 Mn in 2027 from US$ 68.38 Mn in 2019. The market is estimated to grow with a CAGR of 5.3% from 2020 to 2027. Key factors driving the South and Central America cell line development serum market’s growth are increasing adoption of regenerative...

  • Cell Therapy
  • Central America
  • Cancer Incidence
  • Foreign Direct Investment

Regenerative Medicine Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Regenerative Medicine market including the COVID-19 pandemic implications...

  • Regenerative Medicine
  • APAC
  • Central America

The global 3D cell culture market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized...

  • Cell Therapy
  • World
  • Europe
  • North America
  • APAC
  • Cancer Incidence
  • Meat Production

The global regenerative medicine market reached a value of US$ 14.78 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 50.44 Billion by 2027, exhibiting a CAGR of 22.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Regenerative Medicine
  • World

The global 3D bioprinting market was valued at USD 724.17 million in 2020 and is expected to reach USD 2398.27 million by 2026 and grow at a CAGR of 21.91% over the forecast period (2021-2026). The global 3D bioprinting market is expected to experience growth, owing to its revolutionary breakthrough in healthcare and pharmaceutical industries. -...

  • Regenerative Medicine
  • Research And Development
  • Drug Testing
  • Injectable Delivery
  • Medical Biotechnology
  • APAC
  • Health Provider Density
  • Elderly Population

The Asia Pacific cell line development serum market is expected to reach US$ 362.87 million in 2027 from US$ 215.68 million in 2019. The market is estimated to grow with a CAGR of 6.7% from 2020 to 2027. Increasing adoption of regenerative medicines, rising prevalence of cancer across the world, and increasing investments in R&D by pharmaceutical...

  • Cell Therapy
  • APAC
  • Foreign Direct Investment
  • Gross Domestic Product

The North America cell line development serum market is expected to reach US$ 502.91 million in 2027 from US$ 307.29 million in 2019. The market is expected to grow with a CAGR of 6.4% from 2020-2027. Increasing adoption of regenerative medicines, rising prevalence of cancer across the world, and increasing investments in R&D by pharmaceutical...

  • Cell Therapy
  • North America
  • Cancer Incidence
  • Health Expenditure

Abstract: - Global Cell Line Development Market to Reach $10.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cell Line Development estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 12.3% over the analysis period 2020-2027....

  • Cell Therapy
  • World
  • China
  • United States